Anti-(+) -methamphetamine monoclonal antibodies
AssigneeBoard of Trustees of the University of Arkansas
InventorsSamuel Michael Owens, Ralph Henry, Alicia Brown
Life of this patent
Estimating the term…
Abstract
The present invention encompasses compositions and methods for effectively treating at least one symptom or sign of methamphetamine use, or for slowing the rate of (+) methamphetamine entry into the brain of a subject. The method comprises administering an effective amount of an anti-(+) methamphetamine antibody to a subject.
Claims20
An isolated antibody, wherein the antibody specifically binds (+) methamphetamine and comprises a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO:10 with zero to two amino acid substitutions.
An isolated antibody capable of specifically binding (+) methamphetamine and comprising a light chain CDR3 comprising the amino acid sequence of SEQ ID NO:
- 7 with zero to two amino acid substitutions.
Dependencies are inferred from the claim text.